Daily non-political popular news in brief.

PSA is poor predictor of lethal prostate cancer

The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute.

Read more »

Keywords: psa, poor, predictor, lethal, prostate, cancer

« Previous | Next »

Similar news on "PSA is poor predictor of lethal prostate cancer":

1. High pretreatment PSA velocity predicts worse outcome
   05-25-2007 · EurekAlert!
   The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.
   Similar news · Read more »
   
2. Statin use linked with decreased prostate cancer mortality rates, lower PSA levels
   05-20-2007 · EurekAlert!
   In recent years, research has indicated a possible link between dietary fat intake and prostate cancer. Research presented today at the 102nd Annual Scientific Meeting of the American Urological Association explores the effect statin medications (which work to reduce low-density lipoprotein, or LDL, levels) may have on prostate-specific antigen, the incidence of prostate cancer, and mortality due to prostate cancer.
   Similar news · Read more »
   
3. Finasteride artificially lowers prostate screening levels
   12-05-2006 · UT Southwestern Medical Center
   The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found.
   Similar news · Read more »
   
4. Gene's activity points to more lethal subtype of AML
   07-09-2007 · EurekAlert!
   A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy. The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.
   Similar news · Read more »
   
5. Using additional biopsy-scoring data may help determine prostate cancer prognosis
   10-02-2007 · EurekAlert!
   Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.
   Similar news · Read more »
   
6. Elderly, ill men get unneeded prostate cancer screenings
   11-14-2006 · EurekAlert!
   A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.
   Similar news · Read more »
   
7. Study identifies characteristics of clinicians likely to order inappropriate prostate screenings
   07-09-2007 · EurekAlert!
   Prostate-specific antigen tests to screen for prostate cancer are frequently performed among patients for whom the PSA test is not shown to be beneficial, and clinicians with certain characteristics are more likely to order such inappropriate screening tests, according to a report in the July 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
   Similar news · Read more »
   
8. Prostate cancer: Watchful wait or vaccinate?
   02-01-2008 · EurekAlert!
   Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the Feb. 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA, a potential diagnostic indicator of prostate cancer
   Similar news · Read more »
   
9. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
   02-14-2008 · EurekAlert!
   An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a man's prostate cancer is going to come back after surgical removal.
   Similar news · Read more »
   
10. Newer approach urged in screening for aggressive prostate cancer
    10-31-2006 · EurekAlert!
    Researchers at the Johns Hopkins University School of Medicine say that how fast the amount of PSA (prostate-specific antigen) in a man's blood increases, or PSA velocity (PSAV), is an accurate gauge of tumor aggression and danger, even when PSA levels are so low as to not warrant a biopsy.
    Similar news · Read more »